These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 29451951

  • 1. Time course and clinical characterization of cisplatin-induced ototoxicity after treatment for nasopharyngeal carcinoma in a South East Asian population.
    Chan SL, Ng LS, Goh X, Siow CH, Goh HL, Goh BC, Cheo T, Loh KS, Brunham LR.
    Head Neck; 2018 Jul; 40(7):1425-1433. PubMed ID: 29451951
    [Abstract] [Full Text] [Related]

  • 2. Sensorineural hearing loss after radiotherapy and chemoradiotherapy: a single, blinded, randomized study.
    Low WK, Toh ST, Wee J, Fook-Chong SM, Wang DY.
    J Clin Oncol; 2006 Apr 20; 24(12):1904-9. PubMed ID: 16622266
    [Abstract] [Full Text] [Related]

  • 3. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Schornagel JH, Dreschler WA, Rasch CR, Balm AJ.
    J Clin Oncol; 2007 Aug 20; 25(24):3759-65. PubMed ID: 17704425
    [Abstract] [Full Text] [Related]

  • 4. Sensorineural Hearing Loss in Nasopharyngeal Carcinoma Survivors in the Modern Treatment Era - The Early and Late Effects of Radiation and Cisplatin.
    Yip PL, Mok KCJ, Ho HS, Lee WYV, Wong ACL, Lau CT, Wong FCS, Yeung KW, Lee SF.
    Clin Oncol (R Coll Radiol); 2022 Apr 20; 34(4):e160-e167. PubMed ID: 34772581
    [Abstract] [Full Text] [Related]

  • 5. A new grading system for ototoxicity in adults.
    Theunissen EA, Dreschler WA, Latenstein MN, Rasch CR, van der Baan S, de Boer JP, Balm AJ, Zuur CL.
    Ann Otol Rhinol Laryngol; 2014 Oct 20; 123(10):711-8. PubMed ID: 24820112
    [Abstract] [Full Text] [Related]

  • 6. Sensorineural hearing loss after treatment of nasopharyngeal carcinoma: a longitudinal analysis.
    Chan SH, Ng WT, Kam KL, Lee MC, Choi CW, Yau TK, Lee AW, Chow SK.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1335-42. PubMed ID: 18922648
    [Abstract] [Full Text] [Related]

  • 7. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients.
    Mahdavi SR, Rezaeyan A, Nikoofar A, Bakhshandeh M, Farahani S, Cheraghi S.
    J Cancer Res Ther; 2020 Apr 01; 16(3):539-545. PubMed ID: 32719264
    [Abstract] [Full Text] [Related]

  • 8. Dose delivery analysis of weekly versus 3-weekly cisplatin concurrent with radiation therapy for locally advanced nasopharyngeal carcinoma (NPC).
    Jagdis A, Laskin J, Hao D, Hay J, Wu J, Ho C.
    Am J Clin Oncol; 2014 Feb 01; 37(1):63-9. PubMed ID: 23111356
    [Abstract] [Full Text] [Related]

  • 9. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
    Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL.
    Cancer; 2006 Feb 15; 106(4):820-9. PubMed ID: 16421885
    [Abstract] [Full Text] [Related]

  • 10. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL, Simis YJ, Lansdaal PE, Rasch CR, Tange RA, Balm AJ, Dreschler WA.
    Audiol Neurootol; 2006 Feb 15; 11(5):318-30. PubMed ID: 16983183
    [Abstract] [Full Text] [Related]

  • 11. Long-term outcome of sensorineural hearing loss in nasopharyngeal carcinoma patients: comparison between treatment with radiotherapy alone and chemoradiotherapy.
    Wei Y, Zhou T, Zhu J, Zhang Y, Sun M, Ding X, Wang D, Li H, Li B.
    Cell Biochem Biophys; 2014 Jul 15; 69(3):433-7. PubMed ID: 24510513
    [Abstract] [Full Text] [Related]

  • 12. Impact of radiation technique, radiation fraction dose, and total cisplatin dose on hearing : Retrospective analysis of 29 medulloblastoma patients.
    Scobioala S, Parfitt R, Matulat P, Kittel C, Ebrahimi F, Wolters H, Am Zehnhoff-Dinnesen A, Eich HT.
    Strahlenther Onkol; 2017 Nov 15; 193(11):910-920. PubMed ID: 28887665
    [Abstract] [Full Text] [Related]

  • 13. Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy.
    Niemensivu R, Saarilahti K, Ylikoski J, Aarnisalo A, Mäkitie AA.
    Eur Arch Otorhinolaryngol; 2016 Sep 15; 273(9):2509-14. PubMed ID: 26685859
    [Abstract] [Full Text] [Related]

  • 14. Concurrent chemoradiotherapy with nedaplatin versus cisplatin in stage II-IVB nasopharyngeal carcinoma: an open-label, non-inferiority, randomised phase 3 trial.
    Tang LQ, Chen DP, Guo L, Mo HY, Huang Y, Guo SS, Qi B, Tang QN, Wang P, Li XY, Li JB, Liu Q, Gao YH, Xie FY, Liu LT, Li Y, Liu SL, Xie HJ, Liang YJ, Sun XS, Yan JJ, Wu YS, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Lv X, Wang L, Xia WX, Zhao C, Cao KJ, Qian CN, Guo X, Hong MH, Nie ZQ, Chen QY, Mai HQ.
    Lancet Oncol; 2018 Apr 15; 19(4):461-473. PubMed ID: 29501366
    [Abstract] [Full Text] [Related]

  • 15. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature.
    Theunissen EA, Bosma SC, Zuur CL, Spijker R, van der Baan S, Dreschler WA, de Boer JP, Balm AJ, Rasch CR.
    Head Neck; 2015 Feb 15; 37(2):281-92. PubMed ID: 24478269
    [Abstract] [Full Text] [Related]

  • 16. Comparison of Patient- and Practitioner-Reported Toxic Effects Associated With Chemoradiotherapy for Head and Neck Cancer.
    Falchook AD, Green R, Knowles ME, Amdur RJ, Mendenhall W, Hayes DN, Grilley-Olson JE, Weiss J, Reeve BB, Mitchell SA, Basch EM, Chera BS.
    JAMA Otolaryngol Head Neck Surg; 2016 Jun 01; 142(6):517-23. PubMed ID: 27149571
    [Abstract] [Full Text] [Related]

  • 17. Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.
    Kwong DL, Wei WI, Sham JS, Ho WK, Yuen PW, Chua DT, Au DK, Wu PM, Choy DT.
    Int J Radiat Oncol Biol Phys; 1996 Sep 01; 36(2):281-9. PubMed ID: 8892450
    [Abstract] [Full Text] [Related]

  • 18. The impact of the cumulative dose of cisplatin during concurrent chemoradiotherapy on the clinical outcomes of patients with advanced-stage nasopharyngeal carcinoma in an era of intensity-modulated radiotherapy.
    Guo SS, Tang LQ, Zhang L, Chen QY, Liu LT, Guo L, Mo HY, Luo DH, Huang PY, Xiang YQ, Sun R, Chen MY, Wang L, Lv X, Zhao C, Guo X, Cao KJ, Qian CN, Zeng MS, Bei JX, Hong MH, Shao JY, Sun Y, Ma J, Mai HQ.
    BMC Cancer; 2015 Dec 16; 15():977. PubMed ID: 26675209
    [Abstract] [Full Text] [Related]

  • 19. The use of high-frequency audiometry increases the diagnosis of asymptomatic hearing loss in pediatric patients treated with cisplatin-based chemotherapy.
    Abujamra AL, Escosteguy JR, Dall'Igna C, Manica D, Cigana LF, Coradini P, Brunetto A, Gregianin LJ.
    Pediatr Blood Cancer; 2013 Mar 16; 60(3):474-8. PubMed ID: 22744939
    [Abstract] [Full Text] [Related]

  • 20. Evoked otoacoustic emissions--an approach for monitoring cisplatin induced ototoxicity in children.
    Stavroulaki P, Apostolopoulos N, Segas J, Tsakanikos M, Adamopoulos G.
    Int J Pediatr Otorhinolaryngol; 2001 May 31; 59(1):47-57. PubMed ID: 11376818
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.